Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $515.7200 (-2.42%) ($513.8100 - $533.1700) on Wed. Apr. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 55 | Latest Price | $515.7200(-2.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.5% a day on average for past five trading days. | Weekly Trend | REGN advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) IVW(36%) SPLV(36%) IWF(35%) | Factors Impacting REGN price | REGN will decline at least -1.885% in a week (0% probabilities). VIXM(-19%) VXX(-7%) UUP(-6%) TBT(-6%) IYT(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $529.96 | 5 Day Moving Average | $544.59(-5.3%) | 10 Day Moving Average | $549.66(-6.17%) | 20 Day Moving Average | $529.96(-2.69%) | To recent high | -9.3% | To recent low | 53.4% | Market Cap | $54.681b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |